CSF3 and Sepsis: Therefore, more RCTs with large number of patients to evaluate clinical parameters and mortality as primary endpoints were needed to investigate the effects of mHLA-DR-guided G-CSF or GM-CSF therapy in patients with sepsis-associated immunosuppression.